Ignite Creation Date:
2025-12-25 @ 4:49 AM
Ignite Modification Date:
2026-05-24 @ 6:08 PM
Study NCT ID:
NCT00114218
Status:
COMPLETED
Last Update Posted:
2019-01-08
First Post:
2005-06-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
Sponsor:
Gynecologic Oncology Group
Organization: